These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10646483)

  • 1. Future trends in the treatment of rheumatoid arthritis: cytokine targets.
    Breedveld FC
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():11-3. PubMed ID: 10646483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mode of action of cytokine inhibitors.
    Arend WP
    J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine network and its manipulation in rheumatoid arthritis.
    Malaviya AM
    J Assoc Physicians India; 2006 Jun; 54 Suppl():15-8. PubMed ID: 16909710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging cytokine targets in rheumatoid arthritis.
    Asquith DL; McInnes IB
    Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
    Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
    Bendele AM; Chlipala ES; Scherrer J; Frazier J; Sennello G; Rich WJ; Edwards CK
    Arthritis Rheum; 2000 Dec; 43(12):2648-59. PubMed ID: 11145022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
    Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
    Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
    Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
    Mullazehi M; Mathsson L; Lampa J; Rönnelid J
    Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
    Andersson AK; Feldmann M; Brennan FM
    Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.